Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study.

Thorlund K, Imberger G, Walsh M, Chu R, Gluud C, Wetterslev J, Guyatt G, Devereaux PJ, Thabane L.

PLoS One. 2011;6(10):e25491. doi: 10.1371/journal.pone.0025491. Epub 2011 Oct 18.

PMID:
22028777
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C.

BMJ. 2011 Jul 26;343:d4169. doi: 10.1136/bmj.d4169. Review.

PMID:
21791495
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD008143. doi: 10.1002/14651858.CD008143.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD008143.

PMID:
21678374
[PubMed - indexed for MEDLINE]
4.

Sequential methods for random-effects meta-analysis.

Higgins JP, Whitehead A, Simmonds M.

Stat Med. 2011 Apr 30;30(9):903-21. doi: 10.1002/sim.4088. Epub 2010 Dec 28.

PMID:
21472757
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT.

N Engl J Med. 2011 Mar 3;364(9):818-28. doi: 10.1056/NEJMoa1006524.

PMID:
21366473
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Effects of moderate intensity glycemic control after cardiac surgery.

Leibowitz G, Raizman E, Brezis M, Glaser B, Raz I, Shapira O.

Ann Thorac Surg. 2010 Dec;90(6):1825-32. doi: 10.1016/j.athoracsur.2010.07.063.

PMID:
21095319
[PubMed - indexed for MEDLINE]
7.

Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Wu H, Xu MJ, Zou DJ, Han QJ, Hu X.

Chin Med J (Engl). 2010 Oct;123(20):2908-13.

PMID:
21034605
[PubMed - indexed for MEDLINE]
Free Article
8.

Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes.

Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, Astor BC, Sharrett AR, Brancati FL, Coresh J.

Diabetes. 2011 Jan;60(1):298-305. doi: 10.2337/db10-1198. Epub 2010 Oct 26.

PMID:
20978092
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Severe hypoglycemia and risks of vascular events and death.

Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S; ADVANCE Collaborative Group.

N Engl J Med. 2010 Oct 7;363(15):1410-8. doi: 10.1056/NEJMoa1003795.

PMID:
20925543
[PubMed - indexed for MEDLINE]
Free Article
10.

Intensified glucose lowering in type 2 diabetes: time for a reappraisal.

Yudkin JS, Richter B, Gale EA.

Diabetologia. 2010 Oct;53(10):2079-85. doi: 10.1007/s00125-010-1864-z. Epub 2010 Aug 5. No abstract available.

PMID:
20686748
[PubMed - indexed for MEDLINE]
11.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group.

Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Epub 2010 Jun 30. Erratum in: Lancet. 2010 Oct 30;376(9751):1466.

PMID:
20594588
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Effects of medical therapies on retinopathy progression in type 2 diabetes.

ACCORD Study Group; ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ.

N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Epub 2010 Jun 29. Erratum in: N Engl J Med. 2011 Jan 13;364(2):190. N Engl J Med. 2012 Dec 20;367(25):2458.

PMID:
20587587
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes.

Hanefeld M, Koehler C, Hoffmann C, Wilhelm K, Kamke W, Gerstein H.

Diabet Med. 2010 Feb;27(2):175-80. doi: 10.1111/j.1464-5491.2009.02915.x.

PMID:
20546261
[PubMed - indexed for MEDLINE]
14.

Diabetes Care Protocol: effects on patient-important outcomes. A cluster randomized, non-inferiority trial in primary care.

Cleveringa FG, Minkman MH, Gorter KJ, van den Donk M, Rutten GE.

Diabet Med. 2010 Apr;27(4):442-50. doi: 10.1111/j.1464-5491.2010.02968.x.

PMID:
20536517
[PubMed - indexed for MEDLINE]
15.

Improving glycaemic control self-efficacy and glycaemic control behaviour in Chinese patients with type 2 diabetes mellitus: randomised controlled trial.

Shi Q, Ostwald SK, Wang S.

J Clin Nurs. 2010 Feb;19(3-4):398-404. doi: 10.1111/j.1365-2702.2009.03040.x.

PMID:
20500279
[PubMed - indexed for MEDLINE]
16.

Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.

Zhang CY, Sun AJ, Zhang SN, Wu CN, Fu MQ, Xia G, Wang KQ, Zou YZ, Ge JB.

Ann Med. 2010 May 6;42(4):305-15. doi: 10.3109/07853891003796752.

PMID:
20429797
[PubMed - indexed for MEDLINE]
17.

The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis.

Marso SP, Kennedy KF, House JA, McGuire DK.

Diab Vasc Dis Res. 2010 Apr;7(2):119-30. doi: 10.1177/1479164109353367. Epub 2009 Dec 4. Review.

PMID:
20382775
[PubMed - indexed for MEDLINE]
Free Article
18.

Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study.

Hage C, Norhammar A, Grip L, Malmberg K, Sarkar N, Svane B, Rydén L.

Diab Vasc Dis Res. 2009 Apr;6(2):71-9. doi: 10.1177/1479164109336042.

PMID:
20368196
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of combination lipid therapy in type 2 diabetes mellitus.

ACCORD Study Group, Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP.

N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Epub 2010 Mar 14. Erratum in: N Engl J Med. 2010 May 6;362(18):1748.

PMID:
20228404
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F.

N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.

PMID:
20228401
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk